Rosita Paleckyte
Rosita Paleckyte is a junior scientist in the Analytical development department in Polpharma Biologics, the Netherlands. Although her educational background focused on molecular biology, she started her career as a research associate in the AD department in Polpharma Biologics. Initially focused mainly on capillary electrophoresis methods, she quickly moved on towards assessment and implementation of […]
Dr. Piotr Mamczur
Dr. Piotr Mamczur is a biotechnology and biopharmaceutical expert with nearly 20 years of experience in protein science, specializing in the production of functional proteins and the development of upstream and downstream processes for antibodies. He is currently a Senior Scientist at Selvita S.A., focusing on antibody drug discovery, with a particular emphasis on antibodies […]
Anand Khristi
Anand Khristi is an accomplished Biopharmaceutical Formulation Scientist at Intas Accord Biopharmaceutical Pvt. Ltd., with deep expertise in the development and commercialization of complex protein-based therapeutics, including high concentration monoclonal antibodies, fusion proteins, and drug conjugates. Anand is adept at driving end-to-end formulation strategies, from conceptualization to large-scale production, with a specialization in lyophilization and […]
Dr. Rebecca Boohaker
Dr. Boohaker is the study director for the oncology department. She designs, oversees, executes and interprets all cancer-related in vivo studies to evaluate potential cancer treatments, including cancer-fighting viruses and other agents that might help combat the disease. Trained primarily as a molecular biologist, Dr. Boohaker’s graduate work at the University of Central Florida resulted […]
Discussion Panel
Challenges in Analytical characterization of mAbs & ADCs and process optimization of cell culture & media Leading experts in the field will focus on critical challenges in analytical characterization of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), as well as process optimization of cell culture and media. The session will address key issues, including advanced […]
